Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.

de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, Ripoche H, Lazar V, Dessen P, Harper F, Pierron G, Pinna G, Araujo N, Harel-Belan A, Armand JP, Wong TW, Soria JC, Kroemer G.

Cancer Res. 2007 Jul 1;67(13):6253-62.

PMID:
17616683
[PubMed - indexed for MEDLINE]
Free Article
2.

Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours.

Jänne PA.

Lung Cancer. 2008 Jun;60 Suppl 2:S3-9. doi: 10.1016/S0169-5002(08)70099-0. Review.

PMID:
18513582
[PubMed - indexed for MEDLINE]
3.

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.

Murphy M, Stordal B.

Drug Resist Updat. 2011 Jun;14(3):177-90. doi: 10.1016/j.drup.2011.02.004. Epub 2011 Mar 24. Review.

PMID:
21435938
[PubMed - indexed for MEDLINE]
4.

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R, Colomer R.

Int J Mol Med. 2007 Jul;20(1):3-10. Review.

PMID:
17549382
[PubMed - indexed for MEDLINE]
5.

Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors.

Giaccone G, Wang Y.

Cancer Treat Rev. 2011 Oct;37(6):456-64. doi: 10.1016/j.ctrv.2011.01.003. Epub 2011 Mar 1. Review.

PMID:
21367530
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Recent advances in non-small cell lung cancer biology and clinical management.

Saintigny P, Burger JA.

Discov Med. 2012 Apr;13(71):287-97. Review.

PMID:
22541616
[PubMed - indexed for MEDLINE]
Free Article
7.

Targeting apoptosis pathways in lung cancer.

Pore MM, Hiltermann TJ, Kruyt FA.

Cancer Lett. 2013 May 28;332(2):359-68. doi: 10.1016/j.canlet.2010.09.012. Epub 2010 Oct 25. Review.

PMID:
20974517
[PubMed - indexed for MEDLINE]
8.

Small-molecule inhibitors of the human epidermal receptor family.

Carter CA, Kelly RJ, Giaccone G.

Expert Opin Investig Drugs. 2009 Dec;18(12):1829-42. doi: 10.1517/13543780903373343. Review.

PMID:
19938898
[PubMed - indexed for MEDLINE]
9.

Cell cycle inhibitors for the treatment of NSCLC.

Shcherba M, Liang Y, Fernandes D, Perez-Soler R, Cheng H.

Expert Opin Pharmacother. 2014 May;15(7):991-1004. doi: 10.1517/14656566.2014.902935. Epub 2014 Mar 25. Review.

PMID:
24666387
[PubMed - indexed for MEDLINE]
10.

The tumor microenvironment in non-small-cell lung cancer.

Graves EE, Maity A, Le QT.

Semin Radiat Oncol. 2010 Jul;20(3):156-63. doi: 10.1016/j.semradonc.2010.01.003. Review.

PMID:
20685578
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Analyses of protein experssion profile to explorer molecular mechanisms of intiation and progression in non-small cell lung cancer].

Yanagisawa K.

Nihon Kokyuki Gakkai Zasshi. 2008 Jan;46(1):71-6. Review. Japanese. No abstract available.

PMID:
18260317
[PubMed - indexed for MEDLINE]
12.

Evading apoptosis in cancer.

Fernald K, Kurokawa M.

Trends Cell Biol. 2013 Dec;23(12):620-33. doi: 10.1016/j.tcb.2013.07.006. Epub 2013 Aug 16. Review.

PMID:
23958396
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk